J Prev Med Public Health.
2006 Sep;39(5):397-403.
Cost-of-illness Study of Asthma in Korea: Estimated from the Korea National Health Insurance Claims Database
- Affiliations
-
- 1Health Insurance Review Agency, Graduate School of Public Health, Yonsei University, Korea. hykang@yumc.yonsei.ac.kr
- 2National Health Personnel Licensing Examination Board, Korea.
- 3Department of Preventive Medicine, College of Medicine, Yonsei University, Korea.
Abstract
-
OBJECTIVES: We estimated the asthma-related health care utilization and costs in Korea from the insurer's and societal perspective.
METHODS: We extracted the insurance claims records from the Korea National Health Insurance claims database for determining the health care services provided to patients with asthma in 2003. Patients were defined as having
asthma if they had > or =2 medical claims with diagnosis of
asthma and they had been prescribed anti-asthma
medicines. Annual claims records were aggeregated for
each patient to produce patient-specific information on the
total utilization and costs. The total asthma-related cost was
the sum of the direct healthcare costs, the transportation
costs for visits to healthcare providers and the patient's or
caregivers' costs for the time spent on hospital or outpatient
visits.
RESULTS: A total of 699,603people were identified as
asthma patients, yielding an asthma prevalence of 1.47%.
Each asthma patient had 7.56 outpatient visits, 0.01 ED
visits and 0.02 admissions per year to treat asthma.The
per-capita insurance-covered costs increased with age,
from 128,276 Won for children aged 1 to 14 years to
270,729 Won for those aged 75 or older. The total cost in
the nation varied from 121,865 million to 174,949 million
Won depending on the perspectives. From a societal
perspective, direct healthcare costs accounted for 84.9%,
transportation costs for 15.1% and time costs for 9.2% of
the total costs.
CONCLUSIONS: Hospitalizations and ED visits represented
only a small portion of the asthma-related costs. Most of
the societal burden was attributed to direct medical
expenditures, with outpatient visits and medications
emerging as the single largest cost components.